| Alternative name1 | CRGF, CT (Teratocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein CR1, TDGF1), Anti-CRIPTO |
| Alternative name2 | CRGF, CT (Teratocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein CR1, TDGF1), CRIPTO |
| Alternative name3 | CRGF, CT (TeRattus norvegicusocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein CR1, TDGF1), CRIPTO |
| Alternative name4 | CRIPTO |
| Alternative name5 | CRGF, CT (Teratocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein CR1, TDGF1), Anti -CRIPTO |
| Other names | N/A, N/A, cryptic protein, one eyed pinhead, one-eyed pinhead, teratocarcinoma-derived growth factor 1, cryptic protein |
| Gene name | N/A |
| Gene name synonims | N/A |
| Other gene names | N/A, N/A, cb85, cripto, tdgf1, wu:fe01d04, zgc:109829, oep |
| Category | Antibodies |
| Clonality | Polyclonal |
| Immunoglobulin isotype | IgG |
| Clone | Polyclonal antibody |
| Host organism | Source: Human, Host: Rabbit |
| Species reactivity | Human |
| Specificity and cross-reactivity | Recognizes human TDGF1 |
| Purification method | Affinity Purified by immunoaffinity chromatography |
| Form/Appearance | 0, 09% sodium azide, Supplied as a liquid in PBS |
| Concentration | N/A |
| Storage and shipping | Aliquot to avoid repeated freezing and thawing, Aliquots are stable for at least 12 months, For maximum recovery of product, For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for: | Immunohistochemistry (IHC), ELISA (EL/EIA) |
| Description | Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory | For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target | CRGF, CT (Teratocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein CR1, TDGF1), CRIPTO |
| Short name | CRGF, CT (Teratocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein CR1, TDGF1) Antibody, CRIPTO |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | CRGF, CT (Teratocarcinoma-derived Growth Factor 1, Cripto-1 Growth Factor, Epidermal Growth Factor-like Cripto Protein complement component (3b/4b) receptor 1 (Knops blood group), teratocarcinoma-derived growth factor 1) (Antibody to), CRIPTO |
| Alternative technique | antibodies |
| Alternative to gene target | C3BR and C4BR and CD35 and KN, CR and CRGF and CRIPTO, CR1 and IDBG-106358 and ENSG00000203710 and 1378, Cell surfaces, TDGF1 and IDBG-409017 and ENSG00000241186 and 6997, Tdgf1 and IDBG-202568 and ENSMUSG00000032494 and 21667, alternative pathway and biological process this GO :0045959 and negative regulation of complement activation, classical pathway and biological process this GO :0009986 and cell surface and cellular component this GO :0030449 and regulation of complement activation and biological process this GO :0045087 and innate immune response and biological process this GO :0045957 and negative regulation of complement activation, classical pathway and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :1900004 and negative regulation of serine-type endopeptidase activity and biological process this GO :1900005 and positive regulation of serine-type endopeptidase activity and biological process, complement component C3b receptor activity, embryo and biological process this GO :0009790 and embryo development and biological process this GO :0009948 and anterior/posterior axis specification and biological process this GO :0009966 and regulation of signal transduction and biological process this GO :0009986 and cell surface and cellular component this GO :0010595 and positive regulation of endothelial cell migration and biological process this GO :0016324 and apical plasma membrane and cellular component this GO :0018105 and peptidyl-serine phosphorylation and biological process this GO :0019897 and extrinsic component of plasma membrane and cellular component this GO :0030154 and cell differentiation and biological process this GO :0030334 and regulation of cell migration and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030509 and BMP signaling pathway and biological process this GO :0030512 and negative regulation of transforming growth factor beta receptor signaling pathway and biological process this GO :0030879 and mammary gland development and biological process this GO :0031225 and anchored component of membrane and cellular component this GO :0035729 and cellular response to hepatocyte growth factor stimulus and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0044344 and cellular response to fibroblast growth factor stimulus and biological process this GO :0045121 and membrane raft and cellular component this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048146 and positive regulation of fibroblast proliferation and biological process this GO :0048471 and perinuclear region of cytoplasm and cellular component this GO :0050731 and positive regulation of peptidyl-tyrosine phosphorylation and biological process this GO :0055007 and cardiac muscle cell differentiation and biological process this GO :0060070 and canonical Wnt signaling pathway and biological process this GO :0071346 and cellular response to interferon-gamma and biological process this GO :0071354 and cellular response to interleukin-6 and biological process this GO :0071356 and cellular response to tumor necrosis factor and biological process this GO :0071364 and cellular response to epidermal growth factor stimulus and biological process, growth factor activity, nuclei, teratocarcinoma-derived growth factor 1, this GO :0000187 and activation of MAPK activity and biological process this GO :0001570 and vasculogenesis and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001763 and morphogenesis of a branching structure and biological process this GO :0001954 and positive regulation of cell-matrix adhesion and biological process this GO :0002042 and cell migration involved in sprouting angiogenesis and biological process this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005615 and extracellular space and cellular component this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005794 and this GO lgi apparatus and cellular component this GO :0007369 and gastrulation and biological process this GO :0007507 and heart development and biological process this GO :0008083 and growth factor activity and molecular function this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0008595 and anterior/posterior axis specification, this GO :0001851 and complement component C3b binding and molecular function this GO :0001855 and complement component C4b binding and molecular function this GO :0001861 and complement component C4b receptor activity and molecular function this GO :0002430 and complement receptor mediated signaling pathway and biological process this GO :0004877 and complement component C3b receptor activity and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006958 and complement activation, this GO :0001851: complement component C3b binding, this GO :0001851: complement component C3b binding and also this GO :0001855: complement component C4b binding and also this GO :0001861: complement component C4b receptor activity and also this GO :0004877: complement component C3b receptor activity, this GO :0001855: complement component C4b binding, this GO :0001861: complement component C4b receptor activity, this GO :0004877: complement component C3b receptor activity, this GO :0005102: receptor binding, this GO :0005102: receptor binding and also this GO :0005515: protein binding and also this GO :0008083: growth factor activity, this GO :0005515: protein binding, this GO :0008083: growth factor activity, complement component (3b/4b) receptor 1 (Knops blood group) |
| Identity | 11701 |
| Gene | TDGF1 |
| Long gene name | teratocarcinoma-derived growth factor 1 |
| Synonyms | CRIPTO CR Cripto-1 |
| Locus | 3p21, 31 |
| Discovery year | 1990-08-02 |
| GenBank acession | M96955 |
| Entrez gene record | 6997 |
| Pubmed identfication | 1882841 10393436 |
| RefSeq identity | NM_003212 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue